Here are some references to scientific studies about flu vaccines.
This does not mean that vaccines should not be given. It means that toxins in the vaccines should be studied - much like lead in food, non-stick coatings on cookware, mercury in water, fish, etc. Vaccines contain the following:
• Formaldehyde -- a known cancer-causing agent
• Aluminum -- a neurotoxin that has been linked to Alzheimer’s disease
• Triton X-100 -- a detergent
• Phenol (carbolic acid)
• Ethylene glycol (antifreeze)
Where are the studies showing that these substances have no effect on those receiving vaccines.
A) Influenza vaccine effectiveness among children 6 to 59 months of age during 2 influenza seasons: a case-cohort study.
Szilagyi PG, Fairbrother G, Griffin MR, Hornung RW, Donauer S, Morrow A, Altaye M, Zhu Y, Ambrose S, Edwards KM, Poehling KA, Lofthus G, Holloway M, Finelli L, Iwane M, Staat MA; New Vaccine Surveillance Network.
Strong Memorial Hospital, Rochester, NY 14642, USA. peter_szilagyi@urmc.rochester.edu
OBJECTIVE: To measure vaccine effectiveness (VE) in preventing influenza-related health care visits among children aged 6 to 59 months during 2 consecutive influenza seasons. DESIGN: Case-cohort study estimating effectiveness of inactivated influenza vaccine in preventing inpatient/outpatient visits (emergency department
and outpatient clinic). We compared vaccination status of laboratory-confirmed influenza cases with a cluster sample of children from a random sample of practices in 3 counties (subcohort) during the 2003-2004 and 2004-2005 seasons. SETTING: Counties encompassing Rochester, New York, Nashville, Tennessee, and Cincinnati, Ohio. PARTICIPANTS: Children aged 6 to 59 months seen in inpatient/ED or outpatient clinic settings for acute respiratory illnesses and community-based subcohort comparison. Main Exposure Influenza vaccination. MAIN OUTCOME MEASURES: Influenza vaccination status of cases vs subcohort using time-dependent Cox proportional hazards models to estimate VE in preventing inpatient/ED and outpatient visits. RESULTS: During the 2003-2004 and 2004-2005 seasons, 165 and 80 inpatient/ED and 74 and 95 outpatient influenza cases were enrolled, while more than 4500 inpatient/ED and more than 600 outpatient subcohorts were evaluated, respectively. In bivariate analyses, cases had lower vaccination rates than subcohorts. However, significant influenza VE could not be demonstrated for any season, age, or setting after adjusting for county, sex, insurance, chronic conditions recommended for influenza vaccination, and timing of influenza vaccination (VE estimates ranged from 7%-52% across settings and seasons for fully vaccinated 6- to 59-month-olds). CONCLUSION: In 2 seasons with suboptimal antigenic match between vaccines and circulating strains, we could not demonstrate VE in preventing influenza-related inpatient/ED or outpatient visits in children younger than 5 years. Further study is needed during years with good vaccine match.
http://www.ncbi.nlm.nih.gov/pubmed/18838647?ordinalpos=10&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum
http://www.ncbi.nlm.nih.gov/pubmed/16437500
B) The remaining evidence base is currently insufficient to indicate the magnitude of the mortality benefit, if any, that elderly people derive from the vaccination programme.
http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6W8X-4PRJTNM-S&_user=10&_coverDate=10%2F31%2F2007&_rdoc=22&_fmt=summary&_orig=browse&_srch=doc-info(%23toc%236666%232007%23999929989%23669378%23FLA%23display%23Volume)&_cdi=6666&_sort=d&_docanchor=&view=c&_ct=26&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=2d5b408b7d441b442bcc0da8f9b9d8bf
C) A study published in the Lancet just found that influenza vaccination was NOT associated with a reduced risk of pneumonia in older people. Research published in the American Journal of Respiratory and Critical Care Medicine also confirms that there has been no decrease in deaths from influenza and pneumonia, despite the fact that vaccination coverage among the elderly has increased from 15 percent in 1980 to 65 percent now.
(source - Mercola newsletter about the importance of Vit D. I read the Mercola newsletters - most of his information is supported by studies performed by reputable institutions. Some of his stuff is just to promote his products - and which I just ignore. I have found many of the comments on the newsletters very interesting, because people have often related personal experiences about various remedies, etc.)